Otsuka Holdings completes MicroPort Scientific share transfer

Otsuka Holdings Co., Ltd. today announced the completion of the share transfer of MicroPort Scientific Corporation. The transfer was executed by Otsuka Medical Devices Co., Ltd., a wholly-owned subsidiary of Otsuka Holdings, to Shanghai MedTech Medical Equipment Partnership Enterprise. The transaction officially concluded on September 22, 2025, as previously anticipated.

This completion follows the share transfer agreement made public on July 25, 2025. MicroPort Scientific Corporation, based in Shanghai with Dr. Zhaohua Chang as chairman and CEO, was an equity-method affiliate for Otsuka Holdings.

The divestment by Otsuka Medical Devices, headquartered in Tokyo with president Noriko Tojo, marks a significant step in the company’s portfolio management. Yuji Kogure, director of investor relations at Otsuka Holdings, confirmed the completion.